Milestone Pharmaceuticals MIST
NASDAQ MIST
$0.70 +0.01 (+1.06%)
At close: Oct 22, 2026 · 4:00 PM EDT

Milestone Pharmaceuticals (MIST) Preferred Stock Liabilities (2018 - 2019)

Updated

Milestone Pharmaceuticals (MIST) reported Preferred Stock Liabilities of -$138.76 million for Q2 2019, compared with $59.1 million a year earlier.

Analysis

Milestone Pharmaceuticals (MIST) Preferred Stock Liabilities (2018 - 2019) Analysis & Trends

At the end of FY2018, Milestone Pharmaceuticals posted Preferred Stock Liabilities of $138.76 million.

  • Per Business Quant data, the three quarters before Q2 2019 came in at $138.76 million (Q1 2019), $138.76 million (Q4 2018) and $59.1 million (Q3 2018).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Milestone Pharmaceuticals 97.49 Mn -73.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 -138.76 Mn
Mar 31, 2019 138.76 Mn
Dec 31, 2018 138.76 Mn
Sep 30, 2018 59.10 Mn
Jun 30, 2018 59.10 Mn
Mar 31, 2018 59.10 Mn
API Access

Milestone Pharmaceuticals Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=MIST&period=max&api_key=YOUR_API_KEY